aesthetic clinics role in glp-1 patient care patients are one of the fastest-growing populations medicine. They come with a unique set of facial aging challenges. Are you prepared to treat them?, Join Kian Karimi MD, FACS, for GLP-1 patients aren't approaching aesthetics

The cyclic structure can protect against enzymatic degradation while maintaining biological activity, potentially expanding the range of conditions treatable with peptide therapeutics

The researchers noted that the use of GLP-1 drugs in people with schizophrenia spectrum conditions helped with comorbid diabetes and obesity

In recent years, the glucagon-like peptide-1 receptor (GLP-1R) has emerged as an important target in the treatment of type II diabetes and obesity 6, 7

Tissue-engineered implants were explored as a potential solution

However, the agency has approved several of these drugs for general weight management

Helmerhorst, E.J., Troxler, R.F., and Oppenheim, F.G., Proc